CRYOVALVE SG PULMONARY VALVE AND CONDUIT
FDA 510(k) clearance K083106 · decided 2009-02-06
Clearance details
- K-number
- K083106
- Device name
- CRYOVALVE SG PULMONARY VALVE AND CONDUIT
- Applicant
- Cryolife, Inc.
- Decision
- Substantially Equivalent
- Date received
- 2008-10-20
- Decision date
- 2009-02-06
- Days to decision
- 109 days
- Clearance type
- Traditional
- Product code
- OHA
- Device class
- U
- Medical specialty
- Unknown
- Advisory committee
- Unknown
- Location
- Kennesaw, GA, US
- Third-party review
- No
- Expedited review
- No
+ Add to Predicate Builder ◉ Watch Cryolife
Need this as data, not a web page?
Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.
Similar devices under this product code
Devices cleared under the same product code - the starting set for predicate research.
| Record | Firm | Date |
|---|---|---|
| CryoValve SG Pulmonary Valve (SGPV10) CryoValve SG Pulmonary Valve and Conduit (SGPV00) (K252059) | Artivion, Inc. | 2025-10-02 |
| CRYOVALVE SG PULMONARY HUMAN HEART VALVE (AND CONDUIT) (K092021) | Cryolife, Inc. | 2010-05-25 |
| HUMAN HEART VALVE, CRYOVALVE SG (K033484) | Cryolife, Inc. | 2008-02-07 |
Recalls involving this device
| Record | Firm | Date |
|---|---|---|
| Pulmonary Valve & Conduit SG Used in heart surgery recall (Z-1219-2011) | CryoLife, Inc. | 2011-02-11 |
PMA approvals by this applicant
| Record | Firm | Date |
|---|---|---|
| BioGlue® Surgical Adhesive (P010003/S042) | Cryolife, Inc. | 2025-03-18 |
| BioGlue® Surgical Adhesive (P010003/S041) | Cryolife, Inc. | 2023-10-20 |
| CardioGenesis TMR System (P970029/S040) | Cryolife, Inc. | 2022-09-01 |
| BioGlue Surgical Adhesive (P010003/S040) | Cryolife, Inc. | 2022-05-25 |
| BioGlue® Surgical Adhesive (P010003/S039) | Cryolife, Inc. | 2021-12-09 |
| BioGlue Surgical Adhesive (P010003/S038) | Cryolife, Inc. | 2021-07-23 |
| TMR Holmium Laser System (P970029/S038) | Cryolife, Inc. | 2021-01-21 |
| BioGlue Surgical Adhesive (P010003/S037) | Cryolife, Inc. | 2019-12-20 |